Company Overview
Snapshot
Founded in May 2022 by Nadav Grossinger, Elio Labs operates with 11–50 employees. The company has raised $21 million across two funding rounds from four investors, with Innovation Endeavors leading a recent round.
Business overview
Elio Labs develops an AI-powered optical imaging platform designed to analyze biological samples with high resolution and in real time. Its core technology integrates advanced optical imaging with artificial intelligence to extract dynamic biological insights from cells and tissues. The company's solution supports applications in drug discovery, disease research, and experimental biology, aiming to improve the speed, accuracy, and scalability of biological data interpretation within the Health Tech & Life Sciences sector.
Strategic signal
This development signals strong investor confidence in the company's innovative approach to combining optical imaging and AI for biological analysis, suggesting a potential for significant advancements in the fields of drug discovery and disease research.
Log in to access full profile ›Company Intelligence Q&A
- When was Elio Labs founded?
- Elio Labs was founded in May 2022 by Nadav Grossinger.
- What is Elio Labs' primary focus?
- Elio Labs focuses on developing an AI-powered optical imaging platform that analyzes biological samples at high resolution and in real time, supporting applications in drug discovery, disease research, and experimental biology.
- Which investors have participated in Elio Labs' funding rounds?
- Innovation Endeavors, Xora Innovation, Resolute Ventures, and UpWest have participated in funding rounds for Elio Labs.
- What is the employee count for Elio Labs?
- Elio Labs currently has 11–50 employees.